ライフサイエンスコーパス: narrow-spectrum

1 For initial treatment, the most narrow-spectrum agent active against the likely pathogen

2 al products has become increasingly rare and narrow-spectrum agents are typically deemed unsuitable f

3 t bacteria, research is now directed towards narrow-spectrum agents rather than broad-spectrum agents

4 in (FDX) is a novel antimicrobial agent with narrow-spectrum and potent bactericidal activity against

5 eatment of CDI and herald the development of narrow-spectrum anti-C. difficile agents that relatively

6 2,4-triazolo[1,5-a]pyrimidines that had good narrow-spectrum antibacterial activity against E. faeciu

7 diagnostic tests to allow pathogen-targeted, narrow-spectrum antibiotic therapy, using short rather t

8 pare the effectiveness of broad-spectrum and narrow-spectrum antibiotic treatment for acute respirato

9 manner, allowing for initial treatment with narrow spectrum antibiotics, and helping to reduce the l

10 These data support the use of narrow-spectrum antibiotics for most children with acute

11 Furthermore, we show that pyocins, narrow-spectrum antibiotics made by other P. aeruginosa

12 Colicins are narrow-spectrum antibiotics produced by and active again

13 Neither broad-spectrum nor narrow-spectrum antibiotics were associated with risk of

14 l or patient-centered outcomes compared with narrow-spectrum antibiotics, and were associated with hi

15 treatment of bacterial skin infections with narrow-spectrum antibiotics, rather than broad-spectrum.

16 Broad-spectrum antibiotics vs narrow-spectrum antibiotics.

17 % for broad-spectrum antibiotics vs 2.7% for narrow-spectrum antibiotics; risk difference for full ma

18 for broad-spectrum antibiotics vs 25.1% for narrow-spectrum antibiotics; risk difference for full ma

19 % for broad-spectrum antibiotics vs 3.1% for narrow-spectrum antibiotics; risk difference for full ma

20 2 for broad-spectrum antibiotics vs 91.5 for narrow-spectrum antibiotics; score difference for full m

21 ted the development of FabI inhibitor 4 with narrow spectrum antimicrobial activity and in vivo effic

22 Narrow spectrum antimicrobial activity has been designed

23 solates of S. lugdunensis are susceptible to narrow-spectrum antimicrobial agents.

24 selective ribosomal inhibition and excellent narrow-spectrum antitubercular activity.

25 s, rmPCR/AS 45 hours; P = .01) and increased narrow-spectrum beta-lactam (control 42 hours, rmPCR 71

26 confidence interval [CI], 1.45-5.42), as was narrow-spectrum beta-lactams (aOR, 3.54; 95% CI, 1.98-6.

27 eplacement of broad-spectrum insecticides by narrow-spectrum Bt crops does not reduce control of pest

28 fluenzae, thus implicating them as potential narrow-spectrum drug targets.

29 95% CI, 1.04-1.14 at 6-11 months of age) but narrow-spectrum drugs were not at any age or frequency.

30 negative predictive value of three types of narrowed spectrum endoscopy (narrow-band imaging [NBI],

31 le pathogen-derived molecular pattern, these narrow-spectrum genes are usually readily overcome.

32 itor valproic acid (VPA) and enhanced by the narrow-spectrum HDAC inhibitor entinostat.

33 2CA acts as narrow-spectrum immunosuppressant that selectively targe

34 Subsequent development has brought forth narrow-spectrum inhibitors with potent in-vivo activity

35 Compared to narrow spectrum lamps, broad spectrum technologies enabl

36 Promysalin was previously described as a narrow spectrum molecule with a unique species-specific

37 phenotypic tests, mycolic acid analysis, and narrow-spectrum nucleic acid probes.

38 st human immunodeficiency virus (HIV) have a narrow spectrum of activity and, more often, have associ

39 We report that a narrow spectrum of amino-acid substitutions within the t

40 s (Traf6DeltaTEC mice) showed a surprisingly narrow spectrum of autoimmunity affecting the liver.

41 We report that in contrast to the narrow spectrum of benign tumors in human NF2 patients,

42 These R. bromii strains encode a narrow spectrum of carbohydrate active enzymes (CAZymes)

43 e the emergence of drug-resistance and their narrow spectrum of coverage.

44 most commonly detected in patients within a narrow spectrum of isolated conotruncal heart defects (m

45 The narrow spectrum of tissues containing RII mutations illu

46 acterial agents that could enable conduct of narrow-spectrum, organism-specific clinical trials and u

47 formation as a nonlethal method, as well as narrow-spectrum pathogen-specific antibiotics, which are

48 microbial modification led to an increase in narrow-spectrum penicillins (p=0.0322).

49 Post-AAT, prescribing of narrow-spectrum penicillins was more likely (adjusted od

50 behaviors are mediated by the compound eye's narrow-spectrum photoreceptors R7 and R8 and their downs

51 he enzyme active sites resemble those of the narrow-spectrum TEM-1 and SHV-1, and not the enlarged si

52 Moreover, we show that microcins can act as narrow-spectrum therapeutics to inhibit enteric pathogen

53 ociated with improved outcomes compared with narrow-spectrum treatment.